SEARCH

SEARCH BY CITATION

References

  • 1
    Editorial. Prevalence, morbidity, and cost of dermatological diseases. Journal of Investigative Dermatology 1979; 73: 395401.
  • 2
    Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, Rebell G, Lesher J, Gerlach B, Ponce-de-Leon GF Ghannoum A, Warner J, Isham N, Elewski B. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. Journal of the American Academy of Dermatology 2000; 43: 641648.
  • 3
    Haneke E, Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. International Journal of Dermatology 1999; 38: 712.
  • 4
    J. Thomas, G. A. Jacobson, C. K. Narkowicz, G. M. Peterson, H. Burnet, Sharpe C. Toenail onychomycosis: an important global disease burden. Journal of Clinical Pharmacy and Therapeutics 2010; 35: 497519.
  • 5
    Loo DS. Onychomycosis in the elderly: drug treatment options. Drugs and Aging 2007; 24: 293302.
  • 6
    Salgo PL, Daniel CR, Gupta AK, Mozena JD, Joseph SW. Onychomycosis disease management. Medical Crossfire: debates, peer exchange and insights in medicine 2003; 4: 117.
  • 7
    Hayutin AM. How population aging differs across countries: a briefing on global demographics. Stanford Centre on longevity 2007. Available at: http://longevity.stanford.edu/files/BriefingGlobal
  • 8
    Elewski BE. Onychomycosis: treatment, quality of life, and economic issues. American Journal of Clinical Dermatology 2000; 1: 1926.
  • 9
    Ele Tan JS, Joseph WS. Common fungal infections of the feet in patients with diabetes mellitus. Drugs and Aging 2004; 21: 101112.
  • 10
    Faergemann J, Baran R. Epidemiology. Clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003; 149: Suppl 65:14.
  • 11
    Effendy I, Lecha M, Feuilhade de Chauvin M., Di Chiacchio N, Baran R. European Onychomycosis Observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol 2005; 19: Suppl 1: 812.
  • 12
    Agathos M. Diagnose und Behandlung von Mykosen. Serie diabetisches Fußsyndrom, Folge 6, MMW-Fortschr Med 2000; Nr. 44.
  • 13
    Ralph DC. 3rd and Elewski BE. The diagnosis of nail fungus infection revisited. Arch Dermatol 2000; 136, 11621164.
  • 14
    Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Nagelproben bei Onychomykose: Vergleichsstudie mit einer Kurettage an drei Stellen des infizierten Nagels. J Dtsch Dermatol Ges 2007; 5: 11081111.
  • 15
    Reischl U, Drosten C, Geißdörfer W, Göbel U, Hoffmann KS, Mauch H, Meyer T, Moter A, von Müller L, Panning M, Rabenau HF, Reiter-Ogawa I, Roth A, Weitz M. Urban & Fischer Verlag in Elsivier 2011; Heft 1, 3. Aufl.
  • 16
    Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistery 2009; 55: 611622.
  • 17
    Khot PD, Fredericks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther 2009; 7: 12011221.